Latest in Threadbare Facilities
Sort by
2 items
-
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global uncertainties.The Wall Street Journal - 1d -
Threadbare facilities, high mortality, cats in the corridors: the realities of life for new Rohingya mothers in Cox’s Bazar
In the world’s largest refugee site, a lack of healthcare coupled with rising gang violence makes the journey to motherhood a perilous one. Photographs by Thomas Cristofoletti/Ruom for the ...The Guardian - 6d
